Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

This publication has 61 references indexed in Scilit:

• Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication
  Molecular Therapy, 2010
• Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2
  Clinical Cancer Research, 2004
• Tumor Lysis Syndrome
  Clinical Journal of Oncology Nursing, 2004
• Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses
  European Journal of Immunology, 2002
• Humanization of an anti-p185HER2 antibody for human cancer therapy.
  Proceedings of the National Academy of Sciences, 1992
• EXPRESSION OF ERBB2 IN HUMAN GASTRIC CARCINOMAS - RELATIONSHIP BETWEEN P185ERBB2 EXPRESSION AND THE GENE AMPLIFICATION
  1990
• EXPRESSION OF THE HER-2/NEU PROTOONCOGENE IN NORMAL HUMAN ADULT AND FETAL TISSUES
  1990
• IN VIVO CELL ACTIVATION FOLLOWING OKT3 ADMINISTRATION
  Transplantation, 1990
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.
  Journal of Clinical Oncology, 1989